Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Silver47 Soil Survey Highlights 15 km High-Grade Vein Network and Outlines New Disseminated Gold Target at Kennedy, Nevada
-
Sylla Gold Extends Final Sananfara Option Payment and Provides Deguefarakole Licence Renewal Update
-
Silver Dollar Provides Update on Exploration Drilling at Its La Joya Silver (Cu-Au) Project
-
XAU Resources Inc. Announces Amendments to Business Combination Agreement with QS Holdings Inc.
-
TNR Gold Receives Non-Binding Acquisition Proposal from Altius Minerals; Enters into Exclusivity Arrangement
-
Physicians and Athletes Share How sam(R) Wearable Ultrasound Keeps Them Moving Through Pain and Recovery
-
QuantumCore Begins Development of Third Critical Technology for Scalable Quantum Computing
-
Albion Crown VCT PLC: Annual Financial Report
-
OpsGuru Named OpenAI Select Partner, Recognizing Its Work Bringing OpenAI Models to Enterprise AWS Environments
-
Ink Different Tattoos Enters Missouri with Arch Nemesis, St. Louis's Most Distinctive Multi-Disciplinary Tattoo Studio
-
Premier American Uranium Reports 10 ft of 0.064% eU₃O₈ in Ongoing Drilling at Kaycee, Wyoming
-
VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy
-
ACLARA AND CAP INAUGURATE METALS AND ALLOYS DEMONSTRATION PLANT
-
Atavistik Bio to Present at the Cure HHT 16th International Scientific Conference
-
C60 Power Celebrates National C60 Day on October 9
-
Olyzon Launches its Agentic Orchestration Platform for Advertising, Live at Advertising Week New York
-
Armata Pharmaceuticals Strengthens Intellectual Property Portfolio with Two Recent Patent Issuances in the United States
-
Studies Link Wholefruit Carob Ingredient by Pharmactive to Better Microbiome Balance and Satiety
-
Ambetter Health Solutions and Marathon Health Expand Access to Primary Care for Members in Indiana and Missouri
-
Danaher Accelerates Life Sciences Research with New AI-powered Autonomous Lab
-
Cadrenal Therapeutics Retains Tungsten Advisors to Lead Formal Strategic Process to Maximize Value of its Orphan Thrombo-Inflammatory Therapeutics
-
Great American Media Names Harry Lang Senior Vice President of Product
-
NexLiving Communities to Present at the Cantech Investment Conference in Toronto
-
Glaukos to Release Third Quarter 2026 Financial Results after Market Close on October 28
-
Kodiak Sciences to Present Clinical Data Across All Three Late-Stage Programs at AAO 2026
-
NMG Develops Low-carbon-Footprint Anode Material Coating Process in Collaboration with McGill University
-
Algoma Central Corporation Increases Quarterly Dividend and Declares Special Dividend
-
AVerMedia and Stereolabs Accelerate AI Vision Deployment with NVIDIA JetPack 7.2
-
Silvia Repurchases an Additional 5% of Shares Outstanding, Bringing Total Repurchases to Approximately 20%
-
Otis Third Quarter 2026 Earnings Advisory
-
Federal Ammunition, Mossberg, and Palladyne AI Launch Joint Development of SwarmShot™, a Modular Autonomous Airborne Counter-UAS System
-
Stepan to Announce Third Quarter 2026 Results on October 28, 2026
-
Valaris Announces Contract Awards and Fleet Status Updates
-
Capital Square’s Nickel Hotel in Charleston Earns MICHELIN Key
-
Q2 Metals Extends Near Surface Mineralization 100 Metres North at the Cisco Lithium Project, Intercepting 134.5 Metres at 1.20% Li₂O and 101.6 Metres at 1.02% Li₂O
-
Paraguayan Air Force Taps Cessna SkyCourier for Multi-Mission Operations
-
Abusix launches 'Abusix Frontline' to invest in long-term partner growth
-
BKV Announces Power Generation Equipment Supply Contract Backed by Agreement with a Leading Investment-Grade Hyperscaler
-
Promega Launches 24-Capillary Spectrum CE System for STR Analysis
-
Pulse Biosciences Achieves Enrollment Target in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation Treatment
-
Ola Sol Introduces Humo, a 100% Agave Wine with the Smoke and Structure of Mezcal, and Partners with Union Beer/Blueprint Spirits in New York
-
Seaport Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial Evaluating GlyphAgoTM in Patients with Generalized Anxiety Disorder and Sleep Disturbance
-
Sono-Tek Announces Fiscal Second Quarter and First Half 2027 Earnings Conference Call
-
Capital City Bank Group, Inc. to Announce Quarterly Earnings Results on Tuesday, October 20, 2026
-
Omni Bridgeway Closes US$1 Billion Legal Finance Fundraise
-
OR Royalties Announces Preliminary Q3 2026 GEO Deliveries
-
Axsome Therapeutics to Report Third Quarter 2026 Financial Results on November 2
-
BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds
-
Amplify ETFs Launches Top 10™ Semiconductors ETF (CPU), Expanding Top 10™ Suite
-
Badass Capital Fund I Reports 39.92% Net Return In Q3 2026
